T/CACM 013-2017 Rheumatoid arthritis: guidelines for the combination of diagnosis and treatment based on syndrome differentiation

Scope

Main technical content: The traditional Chinese medicine name for rheumatoid arthritis is "Wang Li". The "Rheumatoid Arthritis Disease and Treatment Guidelines" were compiled based on the principles of traditional Chinese medicine theory and differential diagnosis and treatment. Through retrieving and sorting out 30 years of literature on the treatment of rheumatoid arthritis with traditional Chinese medicine, combined with modern research results, and after extensive discussion by experts of the Chinese Society of Rheumatology, this guideline was formed. The purpose of this guideline is to standardize the clinical diagnosis and treatment of rheumatoid arthritis with traditional Chinese medicine, provide clinicians with standardized treatment strategies and methods, comprehensively improve the clinical efficacy and research level of traditional Chinese medicine rheumatology, and promote the integration with international academic development. This guideline follows the latest international clinical practice guideline methodology, and within the framework of relevant laws, regulations, and technical documents, combines the unique characteristics of traditional Chinese medicine and clinical practice to conduct evidence-based research on the "Rheumatoid Arthritis Disease and Treatment Guidelines". Based on evidence-based medicine, fully integrating expert experience, and forming recommendations for the treatment of rheumatoid arthritis with traditional Chinese medicine on the basis of broad consensus, so as to ensure the scientificity, practicality, effectiveness, and clinical operability of this guideline. Due to the influence of geography, ethnicity, race, environment, and lifestyle, in the specific implementation process, it should be fully based on clinical actual situations.

Development Information

Related Standards